Paper
Surface-conjugated antimicrobial peptide leucocin a displays high binding to pathogenic gram-positive bacteria.
Published Jan 8, 2014 · Hashem Etayash, L. Norman, T. Thundat
ACS applied materials & interfaces
47
Citations
0
Influential Citations
Abstract
Leucocin A, a representative class IIa bacteriocin, is a ribosomally synthesized antimicrobial peptide (AMP) that displays potent activity against specific gram-positive bacteria. The antibacterial activity of such peptides is preceded by the binding event that can be utilized for studying specific peptide-bacteria interactions. In this study, 37-residue Leucocin A (LeuA) was synthesized using solid-phase peptide synthesis and covalently immobilized on gold substrates from either the N- or C-terminal. Both the peptide monolayers on gold substrates were incubated separately with five strains of gram-positive bacteria and displayed differential binding to different strains with highest binding to pathogenic Listeria monocytogenes . The C-terminally immobilized LeuA showed higher bacterial binding compared to the N-terminally attached LeuA. The full length immobilized LeuA (37-residue) was active as well as displayed higher bacterial binding (73 ± 6 bacteria/100 μm(2)) compared to 24-residue inactive LeuA fragment (40 ± 8 bacteria/100 μm(2)) from the C-terminal region. The high and specific bacterial binding ability of LeuA functionalized surfaces support the potential use of class IIa bacteriocins in antimicrobial peptide-based diagnostic platforms.
Leucocin A-functionalized surfaces show high and specific binding to pathogenic gram-positive bacteria, supporting their potential use in antimicrobial peptide-based diagnostic platforms.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...